<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114343">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01954667</url>
  </required_header>
  <id_info>
    <org_study_id>Anthropometric Measures &amp;GERD</org_study_id>
    <nct_id>NCT01954667</nct_id>
  </id_info>
  <brief_title>Anthropometric Measures and Severity of Gastroesophageal Reflux Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <authority>Egypt: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      evaluate the impact of different anthropometric measures on clinical and endoscopic severity
      of GERD and its relation to serum leptin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>Impact of anthropometric measures on GERD</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>obese and overweight</arm_group_label>
    <description>Group1 (n=30): overweight and obese (BMI ≥25 and/ or WHtR≥0.5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>average body weight</arm_group_label>
    <description>Group2 (n=30): normal weight (BMI ≥ 18 to &lt; 25 and/or WHtR ≥0.4 to &lt;0.5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Control Group (n= 20): healthy subjects, matched for age and gender, were included in this study. All included controls had average weight (BMI ≥ 18 to &lt; 25 and/ or WHtR ≥0.4 to &lt;0.5)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This prospective, case-controlled study included 60 Egyptian patients who attended Ain
        Shams University Hospitals and Theodor Bilharz Research Institute; Cairo, Egypt
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gastro esophageal reflux symptoms (e.g. heart burn, regurgitation, water brash or
             atypical symptoms such as hoarseness of voice, asthma and cough)

          -  complete upper gastrointestinal endoscopy.

        Exclusion Criteria:

          -  Receiving medication for reflux disease (including proton pump inhibitor, histamine
             type 2 receptors blocker, prokinetic agents) in the previous month.

          -  Pregnant woman.

          -  History of upper abdominal surgery.

          -  Severe co-morbidity as cirrhosis, end-stage renal disease and heart failure.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tropical medicine department</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 29, 2013</lastchanged_date>
  <firstreceived_date>September 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Iman Fawzy Montasser</investigator_full_name>
    <investigator_title>Lecturer of tropical medicine , Ain Shams university</investigator_title>
  </responsible_party>
  <keyword>Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
